Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Elatericin B
2. Jsi 124
3. Jsi124
1. 2222-07-3
2. Elatericin B
3. Cucurbitacine (i)
4. Jsi-124
5. 1,2-dehydroelatericin A
6. Nsc-521777
7. Chebi:3947
8. Shq47990ph
9. Nsc-112167
10. (8s,9r,10r,13r,14s,16r,17r)-17-[(e,2r)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-8,10,12,15,16,17-hexahydro-7h-cyclopenta[a]phenanthrene-3,11-dione
11. Nsc521777
12. 19-norlanosta-1,5,23-triene-3,11,22-trione, 2,16,20,25-tetrahydroxy-9-methyl-, (9.beta.,10.alpha.,16.alpha.,23e)-
13. Mls002702902
14. 19-nor-9.beta.,5,23-triene-3,11,22-trione, 9-methyl-2,16,20,25-tetrahydroxy-
15. Jsi 124
16. Dtxsid501015546
17. 19-norlanosta-1,23-triene-3,11,22-trione, 2,16,20,25-tetrahydroxy-9-methyl-, (9.beta.,10.alpha.,16.alpha.)- (va
18. Einecs 218-736-8
19. Nsc 112167
20. Nsc 521777
21. Cucurbitaccine (i)
22. Unii-shq47990ph
23. Nsc-521777elatericin B
24. Chembl387737
25. Schembl2523066
26. Schembl15914446
27. Hy-n1405
28. Zinc4097803
29. Lmst01010110
30. Mfcd09971044
31. Nsc112167
32. Akos024456675
33. Cs-5431
34. Ncgc00388208-02
35. 19-nor-9-beta,10-alpha-lanosta-1,5,23-triene-3,11,22-trione, 9-methyl-2,16,20,25-tetrahydroxy-
36. 19-norlanosta-1,5,23-triene-3,11,22-trione, 2,16,20,25-tetrahydroxy-9-methyl-, (9beta,10alpha,16alpha)-
37. 19-norlanosta-1,5,23-triene-3,11,22-trione, 2,16,20,25-tetrahydroxy-9-methyl-, (9beta,10alpha,16alpha)- (van)
38. 2,16alpha,20,25-tetrahydroxy-9beta-methyl-10alpha-19-norlanosta-1,5,23(e)-triene-3,11,22-trione
39. 28580-39-4
40. Xt170627
41. Elatericin B; Jsi-124; Nsc-521777
42. A4512
43. C08800
44. 222c073
45. Q27106265
46. (4r,9beta,16alpha,23e)-2,16,20,25-tetrahydroxy-9,10,14-trimethyl-4,9-cyclo-9,10-secocholesta-2,5,23-triene-1,11,22-trione
47. (8s,9r,10r,13r,14s,16r,17r)-17-[(e,1r)-1,5-dihydroxy-1,5-dimethyl-2-oxo-hex-3-enyl]-2,16-dihydroxy-4,4,9,13,14-pentamethyl-8,10,12,15,16,17-hexahydro-7h-cyclopenta[a]phenanthrene-3,11-dione
48. (9?,10?,16?,23e)-2,16,20,25-tetrahydroxy-9-methyl-19-norlanosta-1,5,23-triene-3,11,22-trione
49. 2,16,20,25-terahydroxycucurbita-1,5,23-triene-3,11,22-trione - Iberis Umbellata (candytuft)
| Molecular Weight | 514.6 g/mol |
|---|---|
| Molecular Formula | C30H42O7 |
| XLogP3 | 2.7 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 4 |
| Exact Mass | 514.29305367 g/mol |
| Monoisotopic Mass | 514.29305367 g/mol |
| Topological Polar Surface Area | 132 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 1160 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
62
PharmaCompass offers a list of Cucurbitacin I API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cucurbitacin I manufacturer or Cucurbitacin I supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cucurbitacin I manufacturer or Cucurbitacin I supplier.
PharmaCompass also assists you with knowing the Cucurbitacin I API Price utilized in the formulation of products. Cucurbitacin I API Price is not always fixed or binding as the Cucurbitacin I Price is obtained through a variety of data sources. The Cucurbitacin I Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cucurbitacin I manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cucurbitacin I, including repackagers and relabelers. The FDA regulates Cucurbitacin I manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cucurbitacin I API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Cucurbitacin I supplier is an individual or a company that provides Cucurbitacin I active pharmaceutical ingredient (API) or Cucurbitacin I finished formulations upon request. The Cucurbitacin I suppliers may include Cucurbitacin I API manufacturers, exporters, distributors and traders.
Cucurbitacin I Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cucurbitacin I GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cucurbitacin I GMP manufacturer or Cucurbitacin I GMP API supplier for your needs.
A Cucurbitacin I CoA (Certificate of Analysis) is a formal document that attests to Cucurbitacin I's compliance with Cucurbitacin I specifications and serves as a tool for batch-level quality control.
Cucurbitacin I CoA mostly includes findings from lab analyses of a specific batch. For each Cucurbitacin I CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cucurbitacin I may be tested according to a variety of international standards, such as European Pharmacopoeia (Cucurbitacin I EP), Cucurbitacin I JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cucurbitacin I USP).
